Cynthia Smith Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cynthia Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cynthia Smith. Cynthia Smith is Director in Protara Therapeutics, Inc. ($TARA) and in Dicerna Pharmaceuticals Inc ($DRNA) and Director in Dicerna Pharmaceuticals Inc ($DRNA) and Chief Commercial Officer in ZS Pharma, Inc. ($ZSPH) and See Remarks in ZS Pharma, Inc. ($ZSPH) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Spero Therapeutics, Inc. ($SPRO).
Latest Insider Trading Transactions of Cynthia Smith
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, DRNA, TARA, SPRO, ZSPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 01 2021 | TARA | Protara Therapeuti ... | Smith Cynthia | Director | Option Exercise | A | 17.98 | 3,750 | 67,425 | 21,750 | |
Feb 01 2021 | TARA | Protara Therapeuti ... | Smith Cynthia | Director | Option Exercise | A | 17.98 | 18,000 | 323,640 | 18,000 | |
Jan 06 2021 | SPRO | Spero Therapeutics ... | Smith Cynthia | Director | Option Exercise | A | 17.93 | 2,629 | 47,138 | 2,629 | |
Oct 27 2020 | SPRO | Spero Therapeutics ... | Smith Cynthia | Director | Option Exercise | A | 13.52 | 7,500 | 101,400 | 7,500 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Smith Cynthia | Director | Option Exercise | A | 21.61 | 15,000 | 324,150 | 15,000 | |
Jun 16 2020 | DRNA | Dicerna Pharmaceut ... | Smith Cynthia | Director | Option Exercise | A | 0.00 | 3,333 | 0 | 3,333 | |
Jun 09 2020 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
Jun 09 2020 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Sell | S | 12.10 | 4,567 | 55,261 | 37,833 | 42.4 K to 37.8 K (-10.77 %) | |
Jun 09 2020 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Grant | A | 0.00 | 13,700 | 0 | 42,400 | 28.7 K to 42.4 K (+47.74 %) | |
Nov 22 2019 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Buy | P | 3.52 | 15,000 | 52,800 | 28,700 | 13.7 K to 28.7 K (+109.49 %) | |
Jun 21 2019 | DRNA | Dicerna Pharmaceut ... | Smith Cynthia | Director | Option Exercise | A | 15.44 | 25,000 | 386,000 | 25,000 | |
Jun 10 2019 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
Jun 10 2019 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Grant | A | 0.00 | 13,700 | 0 | 13,700 | 0 to 13.7 K | |
Jun 05 2019 | SPRO | Spero Therapeutics ... | Smith Cynthia | Director | Option Exercise | A | 10.67 | 6,073 | 64,799 | 6,073 | |
Mar 29 2019 | SPRO | Spero Therapeutics ... | Smith Cynthia | Director | Option Exercise | A | 12.81 | 12,146 | 155,590 | 12,146 | |
Aug 29 2018 | AKBA | Akebia Therapeutic ... | Smith Cynthia | Option Exercise | A | 8.25 | 25,000 | 206,250 | 25,000 | ||
Aug 15 2018 | DRNA | Dicerna Pharmaceut ... | Smith Cynthia | Option Exercise | A | 14.76 | 25,000 | 369,000 | 25,000 | ||
Aug 15 2018 | DRNA | Dicerna Pharmaceut ... | Smith Cynthia | Option Exercise | A | 14.76 | 25,000 | 369,000 | 25,000 | ||
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 55.57 | 15,076 | 837,773 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 27.16 | 30,246 | 821,481 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 27.16 | 2,791 | 75,804 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 10.92 | 20,520 | 224,165 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 10.92 | 5,504 | 60,127 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | D | 2.13 | 185,230 | 394,244 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Sell | D | 90.00 | 12,598 | 1,133,820 | 0 | 12.6 K to 0 (-100.00 %) |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | M | 10.92 | 9,155 | 100,011 | 20,520 | |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Buy | M | 10.92 | 9,155 | 100,011 | 9,155 | 0 to 9.2 K |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | See Remarks | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | See Remarks | Option Exercise | A | 0.00 | 16,875 | 0 | 16,875 | |
Jul 10 2014 | ZSPH | ZS Pharma, Inc. | Smith Cynthia | Chief Commercial Of ... | Option Exercise | A | 0.00 | 33,037 | 0 | 33,037 |
Page: 1